Creatinine Quantitative Testing Drug
Vietnam·Risk Class TTBYT Loại B·Creatinine2·Abbott Ireland Diagnostics Division·Registered Aug 31, 2023- Analysis ID
- 230002151/PCBB-HN
- Submission ID
- 000.00.19.H26-230811-0030
- Product Type
- Creatinine2
- Manufacturer
- Abbott Ireland Diagnostics Division
- Intended Use
- Creatinine2 testing is performed to quantify creatinine in human serum, plasma, or urine on the ARCHITECT c Systems. Creatinine2 testing is used to support the diagnosis and treatment of kidney diseases, to monitor dialysis, and as a basis for calculation when measuring other analytes in urine.
- Registration Date
- Aug 31, 2023
Companies providing products similar to "Creatinine Quantitative Testing Drug"
Recently registered similar products
Access comprehensive regulatory information for Creatinine Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230002151/PCBB-HN and manufactured by Abbott Ireland Diagnostics Division.
This page provides complete technical specifications, regulatory compliance details, 4 companies making similar products including Ortho-Clinical Diagnostics Inc., Roche Diagnostics (Suzhou) Ltd., and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.